Search for dissertations about: "cancer mortality"

Showing result 6 - 10 of 526 swedish dissertations containing the words cancer mortality.

2. 6. Type IV collagen in breast and colorectal cancer : a potential biomarker of metastatic disease

   Author : Moa Lindgren; Hanna Nyström; Ingrid Ljuslinder; Malin Sund; Kristian Pietras; Umeå universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Colorectal cancer; colorectal liver metastases; breast cancer; breast cancer metastases; tumor marker; biomarker; stroma; type IV collagen;

   Abstract : Background: Metastatic colorectal cancer (mCRC) and metastatic breast cancer (mBC) are two leading causes of cancer-related mortality worldwide. Early detection of metastatic disease is critical, and sensitive, easily accessed and cost-effective biomarkers that can diagnose mBC and mCRC at an early stage would have high clinical value. READ MORE

4. 7. Colorectal Cancer : Audit and Health Economy in Colorectal Cancer Surgery in a Defined Swedish Population

   Author : Pia Jestin; Ulf Gunnarsson; Lars Påhlman; Bengt Glimelius; Jörgen Rutegård; Uppsala universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Surgery; colorectal cancer; colon cancer; rectal cancer; epidemiology; quality assurance; quality control; health economy; survival; hospital category; emergency surgery; lymph nodes; tumour staging; anastomotic leakage; case-control study; surgical complications; Kirurgi; Surgery; Kirurgi;

   Abstract : Colorectal cancer is one of the most common malignancies in Sweden, with more than 5000 new cases annually. Median age at time of diagnosis is approximately 75 years. Owing to the ageing population, the incidence of colorectal cancer is increasing. READ MORE

5. 8. Non-functioning pituitary adenomas and hypopituitarism - studies on morbidity and mortality

   Author : Casper Hammarstrand; Göteborgs universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Non-functioning pituitary adenomas; Hypopituitarism; Glucocorticoid replacement; Growth hormone replacement; Morbidity; Mortality; Cancer; LDL-cholesterol;

   Abstract : Background and aims: Hypopituitarism is most commonly caused by benign pituitary tumors, often resulting in insidious symptoms that develop over a long time. Due to either a mass effect exerted by the tumor, or due to the surgical treatment, hormonal deficiencies may arise, requiring hormone replacement. READ MORE

6. 9. Breast cancer screening with mammography of women 40-49 years in Sweden

   Author : Barbro Numan Hellquist; Håkan Jonsson; Lennarth Nyström; Nea Malila; Umeå universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Cohort; mortality; breast cancer; mammography screening; risk factors; parity; age at first birth; socio-economic status; overdiagnosis; Oncology; onkologi;

   Abstract : Background The debate regarding the lower age limit for mammography service screening is old and lively; a product in part of the lower breast cancer risk in younger ages as well as the limited data available for studies of the younger age group. Recently the idea of inviting only high risk groups has gained momentum, however high risk might not be equivalent to greater benefit from screening. READ MORE

7. 10. Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer

   Author : Johan Rosell; John Carstensen; Olle Stål; Bo Nordenskjöld; Lars Holmberg; Linköpings universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Adjuvant; adverse events; breast cancer; cerebrovascular disease; coronary heart disease; heart failure; lung cancer; second primary cancer; tamoxifen;

   Abstract : The aims of this thesis were to investigate the long-term effects of adjuvant tamoxifen treatment on breast cancer recurrence and mortality, cardiovascular disease, and the incidence of secondary cancer.Between 1982 and 1992, postmenopausal patients with early stage breast cancer were included in a randomized clinical study of 2 or 5 years of postoperative tamoxifen therapy. READ MORE